Resonance Specialties (BOM:524218) Total Liabilities: ₹192.3 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524218 Resonance Specialties Ltd BOM:524218
70 GF Score
Price ₹169.65
GF Value ₹141.58
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Resonance Specialties Total Liabilities?

Resonance Specialties BOM:524218 -0.29% 70 Total Liabilities is ₹192.3 Mil as of Mar. 2026. GuruFocus rates BOM:524218 with a GF Score™ of 70/100 and a GF Value™ of ₹141.58 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Resonance Specialties's Total Liabilities for the quarter that ended in Mar. 2026 was ₹192.3 Mil.

Resonance Specialties's quarterly Total Liabilities declined from Sep. 2025 (₹151.06 Mil) to Dec. 2025 (₹0.00 Mil) but then increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹192.30 Mil).

Resonance Specialties's annual Total Liabilities declined from Mar. 2024 (₹162.77 Mil) to Mar. 2025 (₹115.29 Mil) but then increased from Mar. 2025 (₹115.29 Mil) to Mar. 2026 (₹192.30 Mil).

Resonance Specialties Total Liabilities Historical Data

* Premium members only.

The historical data trend for Resonance Specialties's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Resonance Specialties Total Liabilities Chart

Resonance Specialties Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.70 101.01 162.77 115.29 192.30

Resonance Specialties Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 115.29 0.00 151.06 0.00 192.30
BOM:524218
70GF Score
Resonance Specialties Ltd BOM:524218
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Resonance Specialties Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Resonance Specialties's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=162.599+(11.604+16.541
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+1.552+0)
=192.3

Total Liabilities=Total Assets (A: Mar. 2026 )-Total Equity (A: Mar. 2026 )
=924.673-732.377
=192.3

Resonance Specialties's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=162.599+(11.604+16.541
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+1.552+0)
=192.3

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=924.673-732.377
=192.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of ₹192.3 Mil mean?
Resonance Specialties (BOM:524218) has a Total Liabilities of ₹192.3 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Resonance Specialties and its competitors.
Is Resonance Specialties' Total Liabilities too high?
Resonance Specialties' current Total Liabilities is ₹192.3 Mil. Overall, Resonance Specialties has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Resonance Specialties' Total Liabilities compare to DOW?
Resonance Specialties' Total Liabilities of ₹192.3 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Chemicals company?
A good Total Liabilities depends on the Chemicals industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Resonance Specialties and its competitors. Resonance Specialties's current Total Liabilities is ₹192.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Resonance Specialties stock overvalued right now?
Based on GuruFocus' analysis, Resonance Specialties (BOM:524218) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹141.58, compared to a current price of ₹169.65 — trading 19.8% above its estimated fair value. The current Total Liabilities is ₹192.3 Mil. Resonance Specialties' overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Resonance Specialties (BOM:524218), the current Total Liabilities is ₹192.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Resonance Specialties (BOM:524218) Overvalued in 2026?

Based on GuruFocus' analysis, Resonance Specialties stock appears to be overvalued. The current stock price of ₹169.65 is trading 19.8% above its estimated GF Value™ of ₹141.58. GuruFocus considers Resonance Specialties to be Modestly Overvalued.

Key valuation signals for BOM:524218:

  • Total Liabilities: ₹192.3 Mil
  • GF Value™: ₹141.58 vs. price of ₹169.65 (19.8% above fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the BOM:524218 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Resonance Specialties Business Description

Address Plot No. 54-D, Kandivli Industrial Estate, Kandivli (West), Charkop, Mumbai, MH, IND, 400067
Resonance Specialties Ltd is engaged in the manufacturing of chemicals. The company is manufacturing Pyridine, Picoline, Cynopyridine, and derivatives of the same. Bulk drugs and nutritional products are tolls converted. It delivers pyridine and related products. The company has only one segment which is Chemical Manufacturing. The company also manufactures anti-tuberculosis products such as Isoniazid. Geographically. It operates in India and Outside India. The majority of segment revenue is from Outside India.
70GF Score

Get the complete analysis for BOM:524218

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹169.65
Price
₹141.58
GF Value